BOSTON and LAUSANNE, Switzerland, Oct. 28, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (NASDAQ:SOPH) today announced the company will be participating virtually in the following investor conferences:

Credit Suisse 30th Annual Healthcare Conference; Fireside Chat on Thursday, November 11^th at 2:40pm ET / 8:40pm CET
Piper Sandler 33^rd Annual Healthcare Conference; Presentation available on demand beginning November 22^nd at 10:00am ET / 4:00pm CET
Evercore ISI HealthCONx Conference; Fireside Chat on Tuesday, November 30^th at 8:00am ET / 2:00pm CET

Interested parties may access live and archived webcasts of the presentations on the "Investors" section of the company website at ir.sophiagenetics.com.

About SOPHiA GENETICS

SOPHiA GENETICS (NASDAQ:SOPH) is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by more than 780 hospital, laboratory, and biopharma institutions globally.

Media Contact:

Eliza Bamonti

ebamonti@sophiagenetics.com

Investor Contact:

ir@sophiagenetics.com

SOPHiA GENETICS to Participate in Upcoming November Investor Conferences